{"pmid":32389755,"title":"Advocacy to provide good quality oncology services during the COVID-19 pandemic - Actions at 3-Levels.","text":["Advocacy to provide good quality oncology services during the COVID-19 pandemic - Actions at 3-Levels.","The COVID-19 pandemic is a devastating catastrophe to the whole world, China is the first country seriously affected. This review shows that it is possible to stop wide-spread infection in the country and to provide good quality oncology services even during this challenging period, through concerted efforts with well-organized actions at all levels (National/Municipal, Hospital and Department). The key strategies leading to successful impacts are summarized for sharing. In addition to making practice changes to cope with the adverse realities, oncologists should also work together to raise pragmatic suggestions to policy makers and be strong advocates to protect our patients from the detrimental effect of delay or compromised treatment.","Radiother Oncol","Lee, Anne W M","Xu, Zhi-Yuan","Lin, Lily","Xu, Joy","Yang, Jin","Lee, Eric","Hui, Tim","Cheung, Jacob","32389755"],"abstract":["The COVID-19 pandemic is a devastating catastrophe to the whole world, China is the first country seriously affected. This review shows that it is possible to stop wide-spread infection in the country and to provide good quality oncology services even during this challenging period, through concerted efforts with well-organized actions at all levels (National/Municipal, Hospital and Department). The key strategies leading to successful impacts are summarized for sharing. In addition to making practice changes to cope with the adverse realities, oncologists should also work together to raise pragmatic suggestions to policy makers and be strong advocates to protect our patients from the detrimental effect of delay or compromised treatment."],"journal":"Radiother Oncol","authors":["Lee, Anne W M","Xu, Zhi-Yuan","Lin, Lily","Xu, Joy","Yang, Jin","Lee, Eric","Hui, Tim","Cheung, Jacob"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389755","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.radonc.2020.04.031","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666528580195057664,"score":9.490897,"similar":[{"pmid":32311643,"title":"Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey.","text":["Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey.","The novel severe acute respiratory syndrome coronavirus-2 pandemic is a global health problem, which started to affect China by the end of 2019. In Europe, Italy has faced this novel disease entity (named novel coronavirus disease [COVID-19]) first and severely. COVID-19 represents a significant hurdle for public health services and a potential harm for patients with cancer. The Collegio Italiano dei Primari Oncologi Medici (CIPOMO) is an Italian association of head physicians in oncology departments, which promotes working and research activities in oncology on a national basis. In the midst of the epidemic in Italy, the CIPOMO promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of oncologists and the implementation of containment measures of COVID-19 diffusion. Overall, 122 head physicians participated in this survey, with a homogeneous distribution on the national territory. Results show that the following measures for oncologic patients have been promptly implemented through the whole country: use of protective devices, triage of patients accessing the hospital, delay of non-urgent visits and use of telemedicine. Results of this survey suggest that Italian oncology departments have promptly set a proactive approach to the actual emergency. Oncologists need to preserve the continuum of care of patients, as the benefit of ensuring a well-delivered anti-cancer treatment plan outweighs the risk of COVID-19 infection. International cooperation is an important starting point, as heavily affected nations can serve as an example to find out ways to safely preserve health activity during the pandemic.","Eur J Cancer","Indini, Alice","Aschele, Carlo","Cavanna, Luigi","Clerico, Mario","Daniele, Bruno","Fiorentini, Giammaria","Fioretto, Luisa","Giordano, Monica","Montesarchio, Vincenzo","Ortega, Cinzia","Pinotti, Graziella","Scanni, Alberto","Zamagni, Claudio","Blasi, Livio","Grossi, Francesco","32311643"],"abstract":["The novel severe acute respiratory syndrome coronavirus-2 pandemic is a global health problem, which started to affect China by the end of 2019. In Europe, Italy has faced this novel disease entity (named novel coronavirus disease [COVID-19]) first and severely. COVID-19 represents a significant hurdle for public health services and a potential harm for patients with cancer. The Collegio Italiano dei Primari Oncologi Medici (CIPOMO) is an Italian association of head physicians in oncology departments, which promotes working and research activities in oncology on a national basis. In the midst of the epidemic in Italy, the CIPOMO promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of oncologists and the implementation of containment measures of COVID-19 diffusion. Overall, 122 head physicians participated in this survey, with a homogeneous distribution on the national territory. Results show that the following measures for oncologic patients have been promptly implemented through the whole country: use of protective devices, triage of patients accessing the hospital, delay of non-urgent visits and use of telemedicine. Results of this survey suggest that Italian oncology departments have promptly set a proactive approach to the actual emergency. Oncologists need to preserve the continuum of care of patients, as the benefit of ensuring a well-delivered anti-cancer treatment plan outweighs the risk of COVID-19 infection. International cooperation is an important starting point, as heavily affected nations can serve as an example to find out ways to safely preserve health activity during the pandemic."],"journal":"Eur J Cancer","authors":["Indini, Alice","Aschele, Carlo","Cavanna, Luigi","Clerico, Mario","Daniele, Bruno","Fiorentini, Giammaria","Fioretto, Luisa","Giordano, Monica","Montesarchio, Vincenzo","Ortega, Cinzia","Pinotti, Graziella","Scanni, Alberto","Zamagni, Claudio","Blasi, Livio","Grossi, Francesco"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311643","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ejca.2020.03.024","keywords":["cancer","coronavirus","health care","infection","oncology","pandemic"],"locations":["China","Italy","Italian","Italy","Italian","Italian"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491185004544,"score":144.26645},{"pmid":32408842,"title":"Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.","text":["Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.","Response, action, and adaptation of the way health services are delivered will impact our ability to provide optimized and continuity of care while acting within resource constraints imposed by COVID-19. Care for patients with cancer is particularly important given increased infection rates and worse outcomes from COVID-19 in this patient population, as well as potential adverse outcomes if treatment pathways need to be compromised. In this commentary, we provide a global oncology pharmacy perspective (including both developed and developing nations) on how COVID-19 has impacted access to and delivery of cancer therapies. This perspective was prepared by the International Society of Oncology Pharmacy Practitioners, with input from national and regional oncology pharmacy practice groups (42 practice leaders from 28 countries and regions) who contributed to a snapshot survey between 10 and 22 April 2020. Specifically, we highlight challenges related to safe handling of hazardous drugs and maintaining high-quality medication safety standards that have impacted various stakeholders.","J Oncol Pharm Pract","Alexander, Marliese","Jupp, Jennifer","Chazan, Grace","O'Connor, Shaun","Chan, Alexandre","32408842"],"abstract":["Response, action, and adaptation of the way health services are delivered will impact our ability to provide optimized and continuity of care while acting within resource constraints imposed by COVID-19. Care for patients with cancer is particularly important given increased infection rates and worse outcomes from COVID-19 in this patient population, as well as potential adverse outcomes if treatment pathways need to be compromised. In this commentary, we provide a global oncology pharmacy perspective (including both developed and developing nations) on how COVID-19 has impacted access to and delivery of cancer therapies. This perspective was prepared by the International Society of Oncology Pharmacy Practitioners, with input from national and regional oncology pharmacy practice groups (42 practice leaders from 28 countries and regions) who contributed to a snapshot survey between 10 and 22 April 2020. Specifically, we highlight challenges related to safe handling of hazardous drugs and maintaining high-quality medication safety standards that have impacted various stakeholders."],"journal":"J Oncol Pharm Pract","authors":["Alexander, Marliese","Jupp, Jennifer","Chazan, Grace","O'Connor, Shaun","Chan, Alexandre"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32408842","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/1078155220927450","keywords":["covid-19","isopp","oncology pharmacy","pandemic","pharmacist"],"topics":["Prevention"],"weight":1,"_version_":1666897319097794561,"score":139.20358},{"pmid":32369601,"title":"Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.","text":["Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.","BACKGROUND: Because of the increased risk in cancer patients of developing complications caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGG) during the coronavirus disease 2019 (COVID-19) pandemic. METHOD / RESULTS: 16 international experts in the treatment of HGG contributed to this consensus-based practice recommendation including neuro-oncologists, neurosurgeons, radiation -oncologists and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in two pandemic scenarios, a scale-up phase and a crisis phase. CONCLUSION: This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.","Neuro Oncol","Bernhardt, Denise","Wick, Wolfgang","Weiss, Stephanie E","Sahgal, Arjun","Lo, Simon S","Suh, John H","Chang, Eric L","Foote, Matthew","Perry, James","Meyer, Bernhard","Vajkoczy, Peter","Wen, Patrick Y","Straube, Christoph","Pigorsch, Steffi","Wilkens, Jan J","Combs, Stephanie E","32369601"],"abstract":["BACKGROUND: Because of the increased risk in cancer patients of developing complications caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGG) during the coronavirus disease 2019 (COVID-19) pandemic. METHOD / RESULTS: 16 international experts in the treatment of HGG contributed to this consensus-based practice recommendation including neuro-oncologists, neurosurgeons, radiation -oncologists and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in two pandemic scenarios, a scale-up phase and a crisis phase. CONCLUSION: This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic."],"journal":"Neuro Oncol","authors":["Bernhardt, Denise","Wick, Wolfgang","Weiss, Stephanie E","Sahgal, Arjun","Lo, Simon S","Suh, John H","Chang, Eric L","Foote, Matthew","Perry, James","Meyer, Bernhard","Vajkoczy, Peter","Wen, Patrick Y","Straube, Christoph","Pigorsch, Steffi","Wilkens, Jan J","Combs, Stephanie E"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369601","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/neuonc/noaa113","keywords":["covid-19","sars-cov-2","glioblastoma","high-grade glioma","neuro-oncology"],"topics":["Prevention"],"weight":1,"_version_":1666138496143720450,"score":120.324905},{"pmid":32402764,"title":"Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective.","text":["Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions of people in over 180 territories, causing a significant impact on healthcare systems globally. Older adults, as well as people living with cancer, appear to be particularly vulnerable to COVID-19 related morbidity and mortality, which means that older adults with cancer are an especially high-risk population. This has led to significant changes in the way geriatric oncologists provide care to older patients, including the implementation of novel methods for clinical visits, interruptions or delays in procedures, and modification of therapeutic strategies, both in the curative and palliative settings. In this manuscript, we provide a global overview of the perspectives of geriatric oncology providers from countries across Europe, America, and Asia, regarding the adaptive strategies utilized to continue providing high quality care for older patients with cancer during the COVID-19 pandemic. Through these perspectives, we attempt to show that, although each country and setting has specific issues, we all face similar challenges when providing care for our older patients with cancer during these difficult times.","J Geriatr Oncol","Desideri, Isacco","Pilleron, Sophie","Battisti, Nicolo Matteo Luca","Gomes, Fabio","de Glas, Nienke","Neuendorff, Nina Rosa","Liposits, Gabor","Paredero-Perez, Irene","Lok, Wendy Chan Wing","Loh, Kah Poh","DuMontier, Clark","Mian, Hira","Soto-Perez-de-Celis, Enrique","32402764"],"abstract":["The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions of people in over 180 territories, causing a significant impact on healthcare systems globally. Older adults, as well as people living with cancer, appear to be particularly vulnerable to COVID-19 related morbidity and mortality, which means that older adults with cancer are an especially high-risk population. This has led to significant changes in the way geriatric oncologists provide care to older patients, including the implementation of novel methods for clinical visits, interruptions or delays in procedures, and modification of therapeutic strategies, both in the curative and palliative settings. In this manuscript, we provide a global overview of the perspectives of geriatric oncology providers from countries across Europe, America, and Asia, regarding the adaptive strategies utilized to continue providing high quality care for older patients with cancer during the COVID-19 pandemic. Through these perspectives, we attempt to show that, although each country and setting has specific issues, we all face similar challenges when providing care for our older patients with cancer during these difficult times."],"journal":"J Geriatr Oncol","authors":["Desideri, Isacco","Pilleron, Sophie","Battisti, Nicolo Matteo Luca","Gomes, Fabio","de Glas, Nienke","Neuendorff, Nina Rosa","Liposits, Gabor","Paredero-Perez, Irene","Lok, Wendy Chan Wing","Loh, Kah Poh","DuMontier, Clark","Mian, Hira","Soto-Perez-de-Celis, Enrique"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32402764","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jgo.2020.05.001","keywords":["covid-19","delivery of healthcare","global health","older adults","pandemics"],"locations":["America"],"topics":["Prevention"],"weight":1,"_version_":1666714494919770112,"score":119.77815},{"pmid":32292837,"pmcid":"PMC7102610","title":"Running a Radiation Oncology Department at the time of coronavirus: an Italian experience.","text":["Running a Radiation Oncology Department at the time of coronavirus: an Italian experience.","Starting from Wuhan, China, SARS-CoV-2 has been a catastrophic epidemic involving many countries worldwide. After China, Italy has been heavily affected and severe measures to limit the spread have been taken in the last weeks. Radiation Oncology departments must guarantee optimal cancer treatments even in such a challenging scenario of an ongoing aggressive epidemic. Adopted preventive measures and recommendations are highlighted for patients, professionals and clinical operations to minimize the risk of infection while safely treating cancer patients.","Adv Radiat Oncol","Krengli, Marco","Ferrara, Eleonora","Mastroleo, Federico","Brambilla, Marco","Ricardi, Umberto","32292837"],"abstract":["Starting from Wuhan, China, SARS-CoV-2 has been a catastrophic epidemic involving many countries worldwide. After China, Italy has been heavily affected and severe measures to limit the spread have been taken in the last weeks. Radiation Oncology departments must guarantee optimal cancer treatments even in such a challenging scenario of an ongoing aggressive epidemic. Adopted preventive measures and recommendations are highlighted for patients, professionals and clinical operations to minimize the risk of infection while safely treating cancer patients."],"journal":"Adv Radiat Oncol","authors":["Krengli, Marco","Ferrara, Eleonora","Mastroleo, Federico","Brambilla, Marco","Ricardi, Umberto"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292837","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.adro.2020.03.003","locations":["Wuhan","China","China","Italy","Italian"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138494484873217,"score":109.51316}]}